We have a state-of-the-art process development and cGMP manufacturing center equipped with two GMP suites for cell & gene therapy clinical production and a cell & gene therapy process development pilot plant.
BioCentriq™ has been designed to support the development of cell and gene therapies through innovation and collaboration.
Our clients choose us because we offer fast and cost effective development services that are secure, confidential and flexible.
Services We Provide
BioCentriq™ is available for pre-competitive group sponsored projects and fee-for-service proprietary projects.
We enable rapid growth of new scale-up and manufacturing technologies, customized as needed for each client.
Client teams are welcome to join our staff during project work to facilitate knowledge transfer in a hybrid "hoteling" model. We also have the expertise required to run your projects for you.
Most importantly, we do not retain any intellectual property, all IP belongs solely to you, the client.
Solutions for Cell & Gene Therapies
Narrowing the Skills Gap
We collaborate with large pharmaceutical companies, training partners and funders such as the US government and the National Institute for Innovation in Manufacturing (NIIMBL).
Our goal is to educate the next generation workforce who want to provide general and customized training in cell therapy and biologics manufacturing.
Our Industry Partners
BioCentriq™ and Kytopen® Partner to Demonstrate Impact of Transformative Technology on Cell Therapy ManufacturingMarch 23, 2021
Partnership Enhances Development Capacity of Tevogen Bio’s Proprietary Targeted T cell Therapy for COVID-19March 15, 2021
Cutting-Edge Cell & Gene Therapy Manufacturing Center, BioCentriq™ Opens in Newark, New JerseyOctober 29, 2020
Choosing a CDMO: Top 10 Intangibles Biotech Firms Should ConsiderOctober 22, 2020
Get In Touch
Tell us about your next project or greatest challenge and we'll contact you to discuss how we can help.